You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NPC1

Showing 1 - 25 of 455
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Guangzhou (Dalpiciclib Isetionate Tablets, Camrelizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Dalpiciclib Isetionate Tablets, Camrelizumab
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2023

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Cholesterol metabolism disruption
  • Quebec city, Quebec, Canada
    CHU de Québec-Université Laval
Oct 17, 2022

NPC Trial in Guangzhou (Sintilimab, IBI310)

Active, not recruiting
  • NPC
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 3, 2022

Nasopharyngeal Carcinoma Trial in Shanghai (Anti-EGFR and PD-1 inhibitor arm)

Recruiting
  • Nasopharyngeal Carcinoma
  • Anti-EGFR and PD-1 inhibitor arm
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Nov 26, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel),

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel)
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Sep 17, 2022

Safety and Pharmacokinetics Trial in Shinjuku-Ku (NPC-22, NPC-22 Placebo)

Completed
  • Safety and Pharmacokinetics
  • Shinjuku-Ku, Tokyo, Japan
    Medical Corporation Shinanokai Shinanozaka Clinic
Feb 4, 2022

Nasopharyngeal Carcinoma, Intensity-Modulated Radiotherapy Trial in Zhongshan (Reduction CTVp1, Non-reduction CTVp1)

Recruiting
  • Nasopharyngeal Carcinoma
  • Intensity-Modulated Radiotherapy
  • Reduction CTVp1
  • Non-reduction CTVp1
  • Zhongshan, Guangdong, China
    Zhongshan City People's Hospital
Aug 8, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (BL-B01D1, capecitabine, gemcitabine)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 31, 2023

PD-1 Inhibitor, G-CSF Trial in Guangzhou (Camrelizumab, G-CSF)

Recruiting
  • PD-1 Inhibitor
  • G-CSF
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2022

Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in Guanzhou (HLX07, HLX10, )

Not yet recruiting
  • Nasopharyngeal Carcinoma by AJCC V8 Stage
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 23, 2022

Niemann-Pick Disease, Type C1 Trial in Oakland, Morristown (Hydroxypropyl-beta-cyclodextrin)

Completed
  • Niemann-Pick Disease, Type C1
  • Oakland, California
  • +1 more
Feb 17, 2021

Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Stanford (VK-2019)

Recruiting
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
  • Stanford, California
    Stanford University
Mar 31, 2022

Locally Advanced Nasopharyngeal Carcinoma, Envafolimab, Induction Chemo Trial in Guangzhou (Envafolimab Plus Chemoradiotherapy)

Recruiting
  • Locally Advanced Nasopharyngeal Carcinoma
  • +3 more
  • Envafolimab Plus Chemoradiotherapy
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 9, 2022

Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma Trial in United States (PRO1160)

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Detroit, Michigan
  • +4 more
Jan 31, 2023

Biomarker for Niemann Pick Type C Disease (BioNPC)

Active, not recruiting
  • Niemann-Pick Disease
  • Niemann-Pick Disease, Type C
    • Rostock, Germany
    • +3 more
    May 12, 2021

    Spinal Cord Injury, Acute, Spinal Cord Injury at C4 Level With Complete Lesion, Spinal Cord Injury at C5-C7 Level With Complete

    Recruiting
    • Spinal Cord Injury, Acute
    • +2 more
    • Neural precursor cells derived from human embryonic stem cell line
    • Suwon, Gyeonggido, Korea, Republic of
    • +1 more
    May 3, 2022

    Niemann-Pick Disease, Type C1 Trial in Oakland (Hydroxypropyl-ß-cyclodextrin)

    Active, not recruiting
    • Niemann-Pick Disease, Type C1
    • Oakland, California
      UCSF Benioff Children's Hospital Oakland
    Jun 16, 2021

    Niemann-Pick Disease, Type C Trial in Worldwide (Parts A/B: Adrabetadex, Parts A/B: Sham Control)

    Active, not recruiting
    • Niemann-Pick Disease, Type C
    • Parts A/B: Adrabetadex
    • Parts A/B: Sham Control
    • Birmingham, Alabama
    • +28 more
    Jul 23, 2021

    Nasopharyngeal Carcinoma Trial in China (Toripalimab, Chemotherapy, Intensity modulated radiotherapy)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Guangzhou, Guangdong, China
    • +11 more
    Aug 30, 2022

    Nasopharyngeal Carcinoma Trial in Guangzhou (GP+DDP, Palbociclib, Intensity-modulated radiotherapy)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 2, 2021

    Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8

    Not yet recruiting
    • Stage II Nasopharyngeal Carcinoma AJCC v8
    • +2 more
    • Biopsy
    • +16 more
    • (no location specified)
    Oct 7, 2023

    Nasopharyngeal Tumors Trial in China (Camrelizumab)

    Recruiting
    • Nasopharyngeal Neoplasms
    • Foshan, Guangdong, China
    • +10 more
    May 3, 2022

    Healthy Adult Subjects Trial in Shinjuku (NPC-22, NPC-22 Placebo)

    Completed
    • Healthy Adult Subjects
    • Shinjuku, Tokyo, Japan
      Medical Corporation Shinanokai Shinanozaka Clinic
    Aug 5, 2020

    Niemann-Pick Disease, Type C1 Trial in Worldwide (Hydroxypropyl-beta-cyclodextrin, Placebo)

    Recruiting
    • Niemann-Pick Disease, Type C1
    • Oakland, California
    • +13 more
    Jan 9, 2023

    Nasopharyngeal Carcinoma, EBV-Related Gastric Carcinoma, EBV-Related Leiomyosarcoma Trial in Worldwide (Nanatinostat,

    Recruiting
    • Nasopharyngeal Carcinoma
    • +4 more
    • Lynwood, California
    • +20 more
    Jul 27, 2022